These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 30014596)
1. Epidermal grafting for leukoderma resulting from 1064-nm quality-switched neodymium-doped yttrium aluminium garnet laser toning. Wang YJ; Chang CC Int Wound J; 2018 Dec; 15(6):1045-1048. PubMed ID: 30014596 [TBL] [Abstract][Full Text] [Related]
2. Induction of melasma by 1064-nm Q-switched neodymium:yttrium-aluminum-garnet laser therapy for acquired bilateral nevus of Ota-like macules (Hori nevus): A study on related factors in the Chinese population. Wang B; Xie HF; Tan J; Xie HJ; Xu LY; Ding R; Liu FF; Chen X; Jian D; Li J J Dermatol; 2016 Jun; 43(6):655-61. PubMed ID: 26777390 [TBL] [Abstract][Full Text] [Related]
3. Influence of the frequency of laser toning for melasma on occurrence of leukoderma and its early detection by ultraviolet imaging. Sugawara J; Kou S; Kou S; Yasumura K; Satake T; Maegawa J Lasers Surg Med; 2015 Feb; 47(2):161-7. PubMed ID: 25663133 [TBL] [Abstract][Full Text] [Related]
4. Punctate leucoderma after 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low-fluence therapy: is it melanocytopenic or melanopenic? Kim T; Cho SB; Oh SH Dermatol Surg; 2010 Nov; 36(11):1790-1. PubMed ID: 20961356 [No Abstract] [Full Text] [Related]
5. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers. Kauvar AN Semin Cutan Med Surg; 2012 Jun; 31(2):126-32. PubMed ID: 22640433 [TBL] [Abstract][Full Text] [Related]
6. Formation of new melasma lesions in the periorbital area following high-fluence, 1064-nm, Q-switched Nd/YAG laser. Lee WJ; Kim YJ; Noh TK; Chang SE J Cosmet Laser Ther; 2013 Jun; 15(3):163-5. PubMed ID: 23656545 [TBL] [Abstract][Full Text] [Related]
7. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy. Ryu HJ; Kim J J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754 [TBL] [Abstract][Full Text] [Related]
8. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194 [TBL] [Abstract][Full Text] [Related]
9. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301 [TBL] [Abstract][Full Text] [Related]
10. A pilot study of a novel dual--pulsed 1064 nm Q-switched Nd: YAG laser to treat Riehl's melanosis. Chung BY; Kim JE; Ko JY; Chang SE J Cosmet Laser Ther; 2014 Dec; 16(6):290-2. PubMed ID: 25046351 [TBL] [Abstract][Full Text] [Related]
11. Commentary on Clinical and Histopathological Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser. Morton LM Dermatol Surg; 2016 Apr; 42(4):513-4. PubMed ID: 26949932 [No Abstract] [Full Text] [Related]
13. Clinical and Histopathologic Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser. Hofbauer Parra CA; Careta MF; Valente NY; de Sanches Osório NE; Torezan LA Dermatol Surg; 2016 Apr; 42(4):507-12. PubMed ID: 26963146 [TBL] [Abstract][Full Text] [Related]
14. Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium:yttrium-aluminium-garnet laser. Kim JE; Chang SE; Yeo UC; Haw S; Kim IH Clin Exp Dermatol; 2013 Mar; 38(2):167-71. PubMed ID: 23397944 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Zhou X; Gold MH; Lu Z; Li Y Dermatol Surg; 2011 Jul; 37(7):962-70. PubMed ID: 21615824 [TBL] [Abstract][Full Text] [Related]
16. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling. Vachiramon V; Sahawatwong S; Sirithanabadeekul P Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554 [TBL] [Abstract][Full Text] [Related]
17. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser. A comparative study. Tse Y; Levine VJ; McClain SA; Ashinoff R J Dermatol Surg Oncol; 1994 Dec; 20(12):795-800. PubMed ID: 7798410 [TBL] [Abstract][Full Text] [Related]
18. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules. Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691 [TBL] [Abstract][Full Text] [Related]
19. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients. Moubasher AE; Youssef EM; Abou-Taleb DA Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546 [TBL] [Abstract][Full Text] [Related]
20. The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium: Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians: Prospective, Randomized, and Split-Face Comparative Study. Kaminaka C; Furukawa F; Yamamoto Y Dermatol Surg; 2017 Sep; 43(9):1120-1133. PubMed ID: 28328709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]